Exosome-based immunotherapy as an innovative therapeutic approach in melanoma

• Published in: Cell communication and signaling 2024-10, Vol.22 (1), p.527-20, Article 527
• Main Authors: Babaei, Shabnam, Fadaee, Manouchehr, Abbasi-Kenarsari, Hajar, Shanehbandi, Dariush, Kazemi, Tohid
• Format: Article
• Language: English
• Subjects: Animals; Antimitotic agents; Antineoplastic agents; B cells; Cancer; Cancer vaccine; Care and treatment; Chemotherapy; Drug delivery; Drug delivery systems; Drug resistance; Drugs; Exosome therapy; Exosomes - immunology; Exosomes - metabolism; Health aspects; Humans; Immunotherapy; Immunotherapy - methods; Innovations; Medical research; Medicine, Experimental; Melanoma; Melanoma - immunology; Melanoma - pathology; Melanoma - therapy; Metastasis; Nucleic acids; Physiological aspects; Proteins; Review; Skin cancer; Tumor Microenvironment - immunology; Vehicles
• ISSN: 1478-811X; 1478-811X
• DOI: 10.1186/s12964-024-01906-1

The malignant form of melanoma is one of the deadliest human cancers that accounts for almost all of the skin tumor-related fatalities in its later stages. Achieving an exhaustive understanding of reliable cancer-specific markers and molecular pathways can provide numerous practical techniques and direct the way toward the development of rational curative medicines to increase the lifespan of patients. Immunotherapy has significantly enhanced the treatment of metastatic and late-stage melanoma, resulting in an incredible increase in positive responses to therapy. Despite the increasing occurrence of melanoma, the median survival rate for patients with advanced, inoperable terminal disease has increased from around six months to almost six years. The current knowledge of the tumor microenvironment (TME) and its interaction with the immune system has resulted in the swift growth of innovative immunotherapy treatments. Exosomes are small extracellular vesicles (EVs), ranging from 30 to 150 nm in size, that the majority of cells released them. Exosomes possess natural advantages such as high compatibility with living organisms and low potential for causing immune reactions, making them practical for delivering therapeutic agents like chemotherapy drugs, nucleic acids, and proteins. This review highlights recent advancements in using exosomes as an approach to providing medications for the treatment of melanoma.